Crucially, the dual AAV‐delivered PE system effectively and precisely corrected the target mutation, restored PDE6A expression, preserved photoreceptors, and rescued retinal function in Pde6a mice, thereby demonstrating its potential in treating RP. This evidence concerns the gene PDE6A and retinitis pigmentosa 1.